In vitro diagnostics (IVD) is the technique in which medical devices and reagents are used to examine specimens such as blood, urine, stool, tissues, and other body fluids of human body for detection of diseases, conditions, and infections; in an in-vitro environment.... Research Beam Model: Research Beam Product ID: 2019224 3390 USD New
Asia-Pacific IVD Market by Product Type (Reagents, Instruments, and Software & Services), by Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and by End Users (Standalone Laboratory, Hospitals, Academic and Medical Schools, Point of Care Testing, and Others) - Opportunity Analysis and Industry Forecast, 2017-2023

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Asia-Pacific IVD Market by Product Type (Reagents, Instruments, and Software & Services), by Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and by End Users (Standalone Laboratory, Hospitals, Academic and Medical Schools, Point of Care Testing, and Others) - Opportunity Analysis and Industry Forecast, 2017-2023

 
  • Category : Healthcare
  • Published On : September  2017
  • Pages : 180
 
 

In vitro diagnostics (IVD) is the technique in which medical devices and reagents are used to examine specimens such as blood, urine, stool, tissues, and other body fluids of human body for detection of diseases, conditions, and infections; in an in-vitro environment. 

The Asia-Pacific IVD market is driven by rise in geriatric population and rapid expansion of government healthcare expenditure. In addition, increase in awareness of personalized medicine and preventive healthcare measures boost the market share. Furthermore, rise in prevalence of communicable and non-communicable diseases are anticipated to increase the demand of diagnosis, thereby increasing the market growth. However, stringent

government regulations associated with the safety and efficacy of IVD products is expected to hinder the growth of the market during the forecast period. The emerging economies of the Asia-Pacific regions offer lucrative growth opportunities to IVD during the forecast period. The Asia-Pacific IVD market accounted for $13,680 million in 2016, and is estimated to reach at $19,888 million by 2023, growing at a CAGR of 5.4% from 2017–2023.

The market is segmented on the basis of product type, techniques, application, end-user, and country. By product type, the market is categorized into reagents, instruments, and software & services. On the basis of techniques, it is categorized into immunodiagnostics, blood testing, molecular diagnostics, tissue diagnostics, clinical chemistry, and other IVD techniques. Application segment covered in the study include infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and other indications. Based on end-user, it is classified into, hospitals, academic and medical schools, point of care testing, and others. Country-wise, it is analyzed across India, China, Japan, South Korea, Australia, and Rest of Asia-Pacific.

KEY BENEFITS FOR STAKEHOLDERS

  •  The study provides an in-depth analysis of the Asia-Pacific IVD market, with current trends and future estimations to elucidate the investment pockets.
  •  Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  •  The report provides a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
  •  Extensive analysis of different segments facilitates to understand various products of the market. 
  •  Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.

KEY MARKET SEGMENTS

 By Product Type

  •  Reagents 
  •  Instruments 
  •  Software and Services

 By Techniques 

  •  Immunodiagnostics
    •  Enzyme-Linked Immunosorbent Assay (ELISA)
      •  Chemiluminescence Immunoassays (CLIAS)
      •  Fluorescence Immunoassays (FIAS)
      •  Colorimetric Immunoassays (CIS)
    •  Rapid Tests
    •  Enzyme-Linked Immunospot Assays (ELISPOT) 
    •  Radioimmunoassay
    •  Western Blot
  •  Blood Testing
  •  Molecular Diagnostics
    •  Polymerase Chain Reaction (PCR)
    •  Isothermal Nucleic Acid Amplification Technology (INAAT)
    •  Hybridization
    •  DNA Diagnostics
    •  Microarrays
    •  Others
  •  Tissue Diagnostics
  •  Clinical Chemistry 
    •  Basic Metabolic Panel
    •  Liver Panel
    •  Lipid Profile
    •  Thyroid Function Panel
    •  Renal Profile
    •  Electrolyte Panel
    •  Specialty Chemicals
  •  Other IVD Techniques

 By Application 

  •  Infectious Diseases 
  •  Cancer 
  •  Cardiac Diseases 
  •  Immune System Disorders
  •  Nephrological Diseases
  •  Gastrointestinal Diseases
  •  Other Indications

 By End Users

  •  Standalone Laboratory
  •  Hospitals
  •  Academic and Medical Schools
  •  Point of Care Testing
  •  Others 

 By Country

  •  Japan
  •  China
  •  India
  •  South Korea
  •  Australia
  •  Rest of Asia-Pacific

 List of players profiled in the report

  •  Thermo Fisher Scientific Inc.
  •  Alere Inc.
  •  Biomerieux 
  •  Danaher Corporation
  •  F. Hoffmann-La Roche AG
  •  Becton Dickinson and Company
  •  Bio-Rad Laboratories
  •  Bayer AG
  •  Sysmex Corporation
  •  Johnson & Johnson

CHAPTER 1 INTRODUCTION

1.1 REPORT DESCRIPTION
1.2 KEY BENEFITS
1.3 KEY MARKET SEGMENTS
1.4 RESEARCH METHODOLOGY

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1 MARKET DEFINITION AND SCOPE
3.2 KEY FINDINGS

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 PORTERS FIVE FORCES ANALYSIS

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Threat of substitute
3.3.5 Competitive rivalry

3.4 MARKET SHARE ANALYSIS, 2016
3.5 MARKET DYNAMICS

3.5.1 Drivers

3.5.1.1 Increasing incidence of chronic and infectious diseases
3.5.1.2 Technological advancements in IVD
3.5.1.3 Emergence of minimal invasive technologies
3.5.1.4 Increasing government expenditures on healthcare
3.5.1.5 Increase in popularity of personalized medicine approach

3.5.2 Restraint

3.5.2.1 Unclear reimbursement policies
3.5.2.2 Stringent regulatory policies

3.5.3 Opportunity

3.5.3.1 Potential opportunities for outsourcing
3.5.3.2 Convergence of new technologies

CHAPTER 4 IVD MARKET, BY PRODUCT TYPE

4.1 OVERVIEW

4.1.1 Market size and forecast

4.2 REAGENTS

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 INSTRUMENTS

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

4.4 SOFTWARE AND SERVICES

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast

CHAPTER 5 IVD MARKET, BY TECHNIQUE

5.1 OVERVIEW

5.1.1 Market size and forecast

5.2 IMMUNODIAGNOSTICS

5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.2.4 Enzyme-linked immunosorbent assay (ELISA)

5.2.4.1 Market size and forecast
5.2.4.2 Chemiluminescence immunoassay (CLIA)

5.2.4.2.1 Market size and forecast

5.2.4.3 Fluorescence immunoassay (FIA)

5.2.4.3.1 Market size and forecast

5.2.4.4 Colorimetric immunoassay (CI)

5.2.4.4.1 Market size and forecast

5.2.5 Rapid tests

5.2.5.1 Market size and forecast

5.2.6 Enzyme-linked immunospot (ELISPOT)

5.2.6.1 Market size and forecast

5.2.7 Radioimmunoassay (RIA)

5.2.7.1 Market size and forecast

5.2.8 Western blot

5.2.8.1 Market size and forecast

5.3 BLOOD TESTING

5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast

5.4 MOLECULAR DIAGNOSTICS

5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.4.4 Polymerize chain reaction (PCR)

5.4.4.1 Market size and forecast

5.4.5 Isothermal nucleic acid technology (INAAT)

5.4.5.1 Market size and forecast

5.4.6 Hybridization

5.4.6.1 Market size and forecast

5.4.7 DNA diagnostics

5.4.7.1 Market size and forecast

5.4.8 Microarray

5.4.8.1 Market size and forecast

5.4.9 Others

5.4.9.1 Market size and forecast

5.5 TISSUE DIAGNOSTICS

5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast

5.6 CLINICAL CHEMISTRY

5.6.1 Key market trends
5.6.2 Key growth factors and opportunities
5.6.3 Market size and forecast
5.6.4 Basic metabolic panel

5.6.4.1 Market size and forecast

5.6.5 Liver panel

5.6.5.1 Market size and forecast

5.6.6 Renal profile

5.6.6.1 Market size and forecast

5.6.7 Lipid profile

5.6.7.1 Market size and forecast

5.6.8 Thyroid function panel

5.6.8.1 Market size and forecast

5.6.9 Electrolyte panel

5.6.9.1 Market size and forecast

5.6.10 Speciality chemicals

5.6.10.1 Market size and forecast

5.7 OTHER IVD TECHNIQUES

5.7.1 Key market trends
5.7.2 Key growth factors and opportunities
5.7.3 Market size and forecast

CHAPTER 6 IVD MARKET, BY APPLICATION

6.1 INFECTIOUS DISEASES

6.1.1 Key market trends
6.1.2 Key growth factors and opportunities
6.1.3 Market size and forecast

6.2 CANCER

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast

6.3 CARDIAC DISEASES

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast

6.4 IMMUNE SYSTEM DISORDERS

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast

6.5 NEPHROLOGICAL DISEASES

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast

6.6 GASTROINTESTINAL DISEASES

6.6.1 Key market trends
6.6.2 Key growth factors and opportunities
6.6.3 Market size and forecast

6.7 OTHERS INDICATIONS

6.7.1 Key market trends
6.7.2 Key growth factors and opportunities
6.7.3 Market size and forecast

CHAPTER 7 IVD MARKET BY END USERS

7.1 STANDALONE LABORATORIES

7.1.1 Market size and forecast

7.2 HOSPITALS

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast

7.3 ACADEMIC AND MEDICAL SCHOOLS

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast

7.4 POINT OF CARE TESTING

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast

7.5 OTHERS END-USER

7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast

CHAPTER 8 ASIA-PACIFIC IVD MARKET

8.1 Key market trends
8.2 Key growth factors and opportunities
8.3 Market size and forecast
8.4 India

8.4.1 Market size and forecast

8.5 China

8.5.1 Market size and forecast

8.6 Japan

8.4.6.1 Market size and forecast

8.7 Australia

8.7.1 Market size and forecast

8.8 South Korea

8.8.1 Market size and forecast

8.9 Rest of Asia-Pacific

8.9.1 Market size and forecast

CHAPTER 9 COMPANY PROFILES

9.1 THERMO FISHER SCIENTIFIC INC.

9.1.1 Company overview
9.1.2 Business performance
9.1.3 Key strategies and development

9.2 ALERE INC.

9.2.1 Company overview
9.2.2 Business performance
9.2.3 Key strategies and developments

9.3 BIOMERIEUX

9.3.1 Company overview
9.3.2 Business performance
9.3.3 Key strategies and developments

9.4 DANAHER CORPORATION

9.4.1 Company overview
9.4.2 Business performance
9.4.3 Key strategies and development

9.5 F. HOFFMANN-LA ROCHE AG

9.5.1 Company overview
9.5.2 Business performance
9.5.3 Key strategies and developments

9.6 BECTON DICKINSON AND COMPANY

9.6.1 Company overview
9.6.2 Business performance
9.6.3 Key strategies and development

9.7 BIO-RAD LABORATORIES

9.7.1 Company overview
9.7.2 Business performance
9.7.3 Key strategies and developments

9.8 BAYER AG

9.8.1 Company overview
9.8.2 Business performance
9.8.3 Key strategies and development

9.9 SYSMEX CORPORATION

9.9.1 Company overview
9.9.2 Business performance
9.9.3 Key strategies and developments

9.10 JOHNSON & JOHNSON

9.10.1 Company overview
9.10.2 Business performance
9.10.3 Key strategies and development

Table of Contents

TABLE 1 INCIDENCE OF DISEASES
TABLE 2 ASIA-PACIFIC IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 3 ASIA-PACIFIC IVD REAGENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 4 ASIA-PACIFIC IVD INSTRUMENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 5 ASIA-PACIFIC IVD SOFTWARE & SERVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 6 ASIA-PACIFIC IVD MARKET BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 7 ASIA-PACIFIC IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY TYPES, 2016-2023 ($MILLION)
TABLE 8 ASIA-PACIFIC IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY COUNTRY,2016-2023 ($MILLION)
TABLE 9 ASIA-PACIFIC IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET FOR ELISA, BY TYPES, 2016-2023 ($MILLION)
TABLE 10 ASIA-PACIFIC IVD BLOOD TESTING TECHNIQUE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 11 ASIA-PACIFIC IVD MOLECULAR DIAGNOSTICS TECHNIQUE MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 12 ASIA-PACIFIC IVD MOLECULAR DIAGNOSTICS TECHNIQUE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 13 ASIA-PACIFIC IVD TISSUE DIAGNOSTICS TECHNIQUE MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 14 ASIA-PACIFIC IVD CLINICAL CHEMISTRY TECHNIQUE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 15 ASIA-PACIFIC OTHER IVD TECHNIQUES MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 16 ASIA-PACIFIC IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 17 ASIA-PACIFIC IVD INFECTIOUS DISEASES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 18 ASIA-PACIFIC IVD CANCER MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 19 ASIA-PACIFIC IVD CARDIAC DISEASES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 20 ASIA-PACIFIC IVD IMMUNE SYSTEM DISORDER MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 21 ASIA-PACIFIC IVD NEPHROLOGICAL DISEASES MARKET, BY COUNTRY, 2016-2023, ($MILLION)
TABLE 22 ASIA-PACIFIC IVD GASTROINTESTINAL DISEASES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 23 ASIA-PACIFIC IVD OTHER INDICATION MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 24 ASIA-PACIFIC IVD MARKET, BY END USER, 2016-2023, ($MILLION)
TABLE 25 ASIA-PACIFIC IVD STANDALONE LABORATORIES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 26 ASIA-PACIFIC IVD HOSPITALS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 27 ASIA-PACIFIC IVD ACADEMIC AND MEDICAL SCHOOLS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 28 ASIA-PACIFIC IVD POINT OF CARE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 29 ASIA-PACIFIC IVD OTHER END-USER MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 30 ASIA-PACIFIC IVD MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 31 ASIA-PACIFIC IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 32 ASIA-PACIFIC IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 33 ASIA-PACIFIC IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 34 ASIA-PACIFIC IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 35 INDIA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 36 INDIA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 37 INDIA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 38 INDIA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 39 CHINA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 40 CHINA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 41 CHINA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 42 CHINA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 43 JAPAN IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 44 JAPAN IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 45 JAPAN IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 46 JAPAN IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 47 CATEGORIZATION OF IVD DEVICES
TABLE 48 AUSTRALIA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 49 AUSTRALIA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 50 AUSTRALIA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 51 AUSTRALIA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 52 SOUTH KOREA IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 53 SOUTH KOREA IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 54 SOUTH KOREA IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 55 SOUTH KOREA IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 56 REST OF ASIA-PACIFIC IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 57 REST OF ASIA-PACIFIC IVD MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 58 REST OF ASIA-PACIFIC IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 59 REST OF ASIA-PACIFIC IVD MARKET, BY END-USER, 2016-2023 ($MILLION)
TABLE 60 THERMO FISHER SCIENTIFIC INC. COMPANY SNAPSHOT
TABLE 61 ALERE INC. COMPANY SNAPSHOT
TABLE 62 BIOMERIEUX COMPANY SNAPSHOT
TABLE 63 DANAHER CORPORATION COMPANY SNAPSHOT
TABLE 64 ROCHE DIAGNOSTICS COMPANY SNAPSHOT
TABLE 65 BECTON DICKINSON AND COMPANY SNAPSHOT
TABLE 66 BIO-RAD LABORATORIES, INC. COMAPNY SNAPSHOT
TABLE 67 BAYER AG COMPANY SNAPSHOT
TABLE 68 SYSMEX CORPORATION COMPANY SNAPSHOT
TABLE 69 JOHNSON & JOHNSON PVT LTD. COMPANY SNAPSHOT

List of Figures

FIGURE 1 MARKET SEGMENTATION
FIGURE 2 TOP INVESTMENT POCKETS
FIGURE 3 TOP WINNING STRATEGIES, 2014-2016 (%)
FIGURE 4 TOP WINNING STRATEGIES: NATURE AND TYPE, 2014-2016
FIGURE 5 PORTERS FIVE FORCES ANALYSIS
FIGURE 6 MARKET SHARE ANALYSIS: IVD MARKET, 2016
FIGURE 7 ASIA-PACIFIC CHEMILUMINESCENCE IMMUNOASSAY (CLISA) MARKET, 2016-2023 ($MILLION)
FIGURE 8 ASIA-PACIFIC FLUORESCENCE IMMUNOASSAY (FIA) MARKET, 2016-2023 ($MILLION)
FIGURE 9 ASIA-PACIFIC COLORIMETRIC IMMUNOASSAY (CI) MARKET, 2016-2023 ($MILLION)
FIGURE 10 ASIA-PACIFIC RAPID TESTS MARKET, 2016-2023 ($MILLION)
FIGURE 11 ASIA-PACIFIC ENZYME-LINKED IMMUNOSPOT (ELISPOT) MARKET, 2016-2023 ($MILLION)
FIGURE 12 ASIA-PACIFIC RADIOIMMUNOASSAY (RIA) MARKET, 2016-2023 ($MILLION)
FIGURE 13 ASIA-PACIFIC WESTERN BLOT TECHNIQUE MARKET, 2016-2023 ($MILLION)
FIGURE 14 ASIA-PACIFIC POLYMERIZE CHAIN REACTION PCR MARKET, 2016-2023 ($MILLION)
FIGURE 15 ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID TECHNOLOGY (INAAT) MARKET, 2016-2023 ($MILLION)
FIGURE 16 ASIA-PACIFIC HYBRIDIZATION MARKET, 2016-2023 ($MILLION)
FIGURE 17 ASIA-PACIFIC DNA DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 18 ASIA-PACIFIC MICROARRAY MARKET, 2016-2023 ($MILLION)
FIGURE 19 ASIA-PACIFIC OTHER MOLECULAR DIAGNOSTIC TECHNIQUE MARKET, 2016-2023 ($MILLION)
FIGURE 20 ASIA-PACIFIC BASIC METABOLIC PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 21 ASIA-PACIFIC LIVER PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 22 ASIA-PACIFIC RENAL PROFILE MARKET, 2016-2023 ($MILLION)
FIGURE 23 ASIA-PACIFIC LIPID PROFILE MARKET, 2016-2023 ($MILLION)
FIGURE 24 ASIA-PACIFIC THYROID FUNCTION PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 25 ASIA-PACIFIC ELECTROLYTE PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 26 ASIA-PACIFIC SPECIALITY CHEMICALS MARKET, 2016-2023 ($MILLION)
FIGURE 27 THERMO FISHER SCIENTIFIC INC.: REVENUE, 2014-2016, ($MILLION)
FIGURE 28 THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 29 THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 30 ALERE INC.: REVENUE, 2014-2016, ($MILLION)
FIGURE 31 ALERE INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 32 ALERE INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 33 BIOMERIEUX REVENUE: 2014-2016 ($MILLION)
FIGURE 34 BIOMERIEUX: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 35 BIOMERIEUX: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 36 DANAHER CORPORATION: REVENUE, 2014-2016 ($MILLION)
FIGURE 37 DANAHER CORPORATION: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 38 DANAHER CORPORATION: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 39 ROCHE DIAGNOSTICS: REVENUE, 2014-2016 ($MILLION)
FIGURE 40 ROCHE DIAGNOSTICS: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 41 BECTON, DICKINSON AND COMPANY: REVENUE, 2014-2016 ($MILLION)
FIGURE 42 BECTON DICKINSON AND COMPANY: REVENUES BY SEGMENT (%) (2016)
FIGURE 43 BECTON DICKINSON AND COMPANY: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 44 BIO-RAD LABORATORIES: REVENUE, 2014-2016 ($MILLION)
FIGURE 45 BIO RAD LABORATORIES, INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 46 BIO RAD LABORATORIES, INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 47 BAYER AG: REVENUE, 2014-2016 ($MILLION)
FIGURE 48 BAYER AG: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 49 SYSMEX CORPORATION: REVENUE, 2014-2016 ($MILLION)
FIGURE 50 SYSMEX CORPORATION: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 51 SYSMEX CORPORATION: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 52 JOHNSON & JOHSNON: REVENUE, 2014 - 2016 ($MILLION)
FIGURE 53 JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 54 JOHNSON & JOHNSON: REVENUE SHARE BY GEOGRAPHY, (%)(2016)